These results suggested that survivin expression was required for the survival and chemoresistance of ovarian cancer cells and, in turn, that domatinostat reduced the viability and increased the chemosensitivity of ovarian cancer cells through downregulation of survivin expression. The gene discussed is BIRC5; the disease is ovarian carcinoma.